Detta är i linje med Lunds universitets s.k. Tredje uppgift om spridning av vetenskaplig information i samverkan med det omgivande samhället. Olika conflicts of interest (COI) kommer att tydligt anges.
Detta webinar är öppet för alla intresserade och utan registrering eller avgift.
Zoom länk till webinariet:
https://lu-se.zoom.us/j/65843494360
Vänliga hälsningar:
Peter M Nilsson, prof/öl, SUS Malmö (chair)
Martin Magnusson, prof/öl, SUS Malmö (co-chair)
Programme
Lunds Universitet. World Heart Association
Round-Table Discussion on Prevention of Diabetes Complications
Venue: Medicinskt Forskningscentrum (MFC), Skane University Hospital, Malmö, Sweden
Time: Tuesday 24 November 2020, between 14:00-16:00 p.m. (CET)
Organizers: The World Heart Federation (WHF), Geneva, and Lund University, Sweden
Local Hosts: Peter M Nilsson, Professor in Clinical Cardiovascular Research, and Martin M Magnusson, Professor in Cardiology, Skane University Hospital, Malmö, Sweden
Stakeholders: Academia, Health Care, Industry, Patient Organization, Media
Web-link:
https://lu-se.zoom.us/j/65843494360
Format: Short 8-min presentations of various experts and stakeholders, followed by 20 min debate and final conclusions 5 min
Programme:
14:00-14:05 Introduction, welcome (Peter M Nilsson, Malmö)
14:05-14:13 The clinical challenge of diabetes complications – overview (Magnus Löndahl, Lund)
14:13-14:21 Roadmap on CVD and diabetes (Laurence Sperling, Co-chair of WHF Roadmap on CVD and diabetes, Atlanta, GA, USA)
14:21-14:29 Diabetes and the heart (Martin Magnusson, Malmö)
14:29-14:37 Diabetes and vascular protection: hypertension and lipids (Peter M Nilsson, Malmö)
14:37-14:45 Diabetes and the Kidney (Anders Christensson, Malmö)
14:45-15:03 Secondary prevention after MI for patients with diabetes (Margrét Leosdottir, Malmö)
15:03-15:11 Drug treatment of diabetes – Old and New (Lars Rydén, Stockholm)
15:11-15:19 The diabetes nurse and the diabetes team (Marianne Lundberg, Malmö)
15:19-15:27 The view from the patients (Petra Westerberg, The Swedish Diabetes Association for Patients, Stockholm)
15:27-15:35 Global perspectives on NCD and public health (Simon Holmesson, WHO, Geneva)
15:35-15:55 Debate (chair: Martin Magnusson) – L. Sperling, L Rydén, M Leosdottir, Magnus Löndahl, and stakeholders from industry
15:55-16:00 Summary and fare-well (Martin Magnusson, Malmö)
Speakers
Peter M Nilsson (chair), MD, PhD, Professor of Clinical Cardiovascular Research, Lund University, and
Consultant at the Dept. Internal Medicine, Skane University Hospital, Malmo, Sweden
Martin Magnusson (co-chair), MD, PhD, FESC, Professor of Cardiology, Lund University, and
Consultant at the Dept. Cardiology, Skane University Hospital, Malmo, Sweden
Anders Christensson, MD, PhD, Professor of Nephrology, Lund University, and
Consultant at the Dept. Nephrology, Skane University Hospital, Malmo, Sweden
Simon Holmesson, Consultant on prevention of NCD, at WHO Alliance, Geneva, Switzerland, and special advisor at Cancerfonden (Cancer Foundation), Stockholm, Sweden
Margrét Leosdottir, MD, PhD, Associate Professor of Cardiology, Lund University, and
Consultant at the Dept. Cardiology, Skane University Hospital, Malmo, Sweden
Marianne Lundberg, RN, is a senior lecturer and trained as a diabetes nurse, now involved in teaching and post-graduate training for diabetes teams
Magnus Löndahl, MD, PhD, Associate Professor of Internal Medicine, Lund University, Dept. Internal Medicine, Skane University Hospital, Lund, Sweden. President of the Swedish Society for Diabetes
Lars Rydén, MD, PhD, FRCP, FESC, Senior Professor of Cardiology, Karolinska Insitute, Stockholm
Laurence Sperling, MD, PhD, FACC, FAHA, FACP, FASPC is the Founder and Director of Preventive Cardiology at the Emory Clinic. He is currently Katz Professor in Preventive Cardiology at the Emory University School of Medicine, GA, USA. In addition, Dr. Sperling is a Professor in the Rollins School of Public Health in Global Health.
Petra Westerberg, Head of ”Diabetesförbundet”, the Swedish Diabetes Association for organizing patients with diabetes, and the Diabetes Research Foundation, ”Diabetesfonden”, Stockholm, Sweden
Nyhetsinfo
www red DiabetologNytt
